These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-002579-17 A double-blind, randomised placebo controlled study of the effects of Acarbose on endothelial function, hemostatic and fibrinolytic plasmatic factors in patients with stable coronary artery disease an... not-yet-due
Ongoing 2004-004403-37 Eine monozentrische, randomisierte, kontrollierte Studie zur Untersuchung von Interferon-beta zur Behandlung der Multiplen-Sklerose (MS)-assoziierten und primären Uveitis intermedia im Vergleich zur S... not-yet-due
Ongoing 2005-001762-13 Energy metabolism of critically ill children treated with lipid emulsion and carnitine not-yet-due
Other 2005-003201-81 GACHE: German trial of Acyclovir and Corticosteroids in Herpes-simplex-virus-Encephalitis. A multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial. not-yet-due
Ongoing 2005-003644-59 A two months study of the utility of Elidel cream 1% (pimecrolimus) in the long term management of atopic hand eczema. not-yet-due
Ongoing 2005-003911-63 Combined Radiochemotherapy with Erbitux (Cetuximab) plus Temozolomide in the primary therapy of Glioblastoma Multiforme (GBM) - Phase I/II Trial not-yet-due
No trial status on register 2005-004151-35 Pharmacokinetics of oral cefuroxime-axetil compared to intravenous cefuroxime in term neonates and possible adjustment of the oral therapy bad-data
Ongoing 2005-004617-15 „Einsatz des Beta-Blockers Esmolol in Kombination mit dem Phosphodiesterase-III-Hemmer Enoximon im Vergleich zur alleinigen Gabe von Esmolol zur Optimierung der Hämodynamik bei Patienten mit koronarer... not-yet-due
Not reported 2005-004677-20 Randomised Phase II/III Study on Sectional Single Agent Gemcitabine and Docetaxel Versus Carboplatine / Gemcitabine Doublet Therapy, both combined Cetuximab in the Treatment of Advanced NSCLC (Stage I... 2013-09-25 due-trials
Not reported 2005-004840-30 ADJUVANT CHEMOTHERAPY WITH PEMETREXED AND CISPLATIN vs. VINORELBINE AND CISPLATIN IN NSCLC IB, IIA, IIB, T3N1: A RANDOMIZED PHASE II STUDY 2014-04-14 due-trials
Completed, but no date 2005-005471-15 Real-time contrast-enhanced sonography of renal transplant recipients accurately predicts chronic allograft nephropathy bad-data
Ongoing 2006-001080-38 Einfluss einer fischölhaltigen Fettemulsion (SMOF®) auf die systemische immunologische Antwort, die Leberfunktion und die Utilisation bei parenteral ernährten Patienten auf einer chirurgischen Intensi... not-yet-due
Ongoing 2006-001146-13 "Investigation of Caspofungin Plasma Concentration and Pharmacokinetic for the Improvement of the Antifungal Therapy in Patients of Surgical Intensive Care Unit" not-yet-due
Completed, but no date 2006-001212-72 Therapie des nodalen Follikulären Non-Hodgkin-Lymphoms (WHO Grad I/II) im klinischen Stadium I / II mittels involved-field Bestrahlung in Kombination mit Rituximab (Mabthera Involved-field Radiotherap... bad-data
Completed, but no date 2006-001732-53 Eine multizentrische, randomisierte, kontrollierte Studie zur Untersuchung von Adalimumab bei der Behandlung verschiedener Formen von refraktärer Uveitis im Vergleich zur Standardtherapie bad-data
Ongoing 2006-001935-23 Real-time contrast-enhanced sonography of renal transplant recipients accurately predicts vascular allograft nephropathy not-yet-due
Ongoing 2006-002056-14 Akute Cholezystitis – Frühe laparoskopische Operation versus antibiotischer Therapie mit elektiver Cholezystektomie im Intervall (ACDC-Studie) (Acute cholecystitis – early laparoscopic surgery versus ... not-yet-due
Ongoing 2006-002338-39 Pharmakokinetik von Linezolid bei Dialyse (pharmacokinetics of linezolid under dialysis) not-yet-due
Ongoing 2006-004349-41 Supportive Schmerztherapie-Studie - Einfluss von Physostigmin auf die patientenkontrollierte Analgesie (PCA) in der postoperativen Phase bei Intensivpatienten not-yet-due
Not reported 2006-004977-91 Inhalative Sedierung mit Sevofluran im Vergleich zu Propofol bei beatmeten, postoperativen Intensivpatienten – Einfluss auf Extubationszeiten und Aufwachverhalten, Nieren- und Leberfunktion, Hämodynam... 2008-03-01 due-trials
Completed, but no date 2006-005308-15 Pilot study of the safety and tolerance of preoperative melatonin application in patients undergoing major liver resection. bad-data
Not reported 2006-006573-24 Prospective influence of bedtime insulin glargine on mobilization and function of endothelial progenitor cells in patients with type 2 diabetes: a partially double-blind, randomized, three-arm unicent... 2009-06-17 due-trials
Not reported 2007-000624-40 PHASE II STUDY TO EVALUATE GLIVEC (IMATINIB MESYLATE) TO INDUCE PROGRESSION ARREST IN AGGRESSIVE FIBROMATOSIS / DESMOID TUMORS NOT AMENABLE TO SURGICAL RESECTION WITH R0 INTENT OR ACCOMPANIED BY UNACC... 2015-09-30 due-trials
Ongoing 2007-002245-20 Evaluation of potential central glucoregulatory compounds to treat/ameliorate the symptoms of schizophrenia: a proof-of-concept study in healthy volunteers not-yet-due
Ongoing 2007-002755-16 Pharmakokinetik von Posaconazol verabreicht über Magensonde - POLICE-Studie (POsaconazoLe via gastrIC tubE) not-yet-due
Ongoing 2007-004309-90 Fahrtüchtigkeit bei Erwachsenen mit Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörung (ADHS) vor und nach 10wöchiger Behandlung mit 40-80 mg Atomoxetin im Vgl. zu unbehandelten Erwachsenen mit ADHS not-yet-due
Not reported 2007-004535-33 Phase II study on curative resectability of not optimally resectable liver and/or lung metastases from colorectal carcinoma (CRC) under intensified chemotherapy (FLOFOXIRI/Bevacizumab). 2011-03-16 due-trials
Completed, but no date 2007-004603-35 Radiotherapy (IMRT), Erbitux And Chemotherapy For Unresectable Carcinomas Of Head and Neck. REACH-Study bad-data
Ongoing 2007-005537-11 Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma or leukemia not-yet-due
Not reported 2007-006014-41 Determination of Diagnostic Accuracy and Added Value of Vasovist®-Enhanced Peripheral MRA in Comparison to Intra-arterial Digital Subtraction Angiography (i.a. DSA) in Patients with Peripheral Artery ... 2010-11-17 due-trials
Ongoing 2007-007792-17 Vasovist®-enhanced MRI in Preoperative Lymph Node Staging of Lung Cancer: Comparison with 18F FDG PET/CT not-yet-due
Not reported 2008-000121-19 A Randomized Multicentre Phase II Trial Comparing Adjuvant Therapy in Patients with Resected Pancreatic Adenocarcinoma Treated with Interferon Alpha-2b and 5-FU Alone or in Combination with Either Ext... 2010-05-14 due-trials
Other 2008-001090-15 Randomized, double-blind Phase II study of Docetaxel + Sorafenib (Nexavar®) versus Docetaxel + Placebo in First-Line treatment of patients with HER2-negative, metastatic breast cancer. not-yet-due
Ongoing 2008-001561-28 Influence of perioperative HES 130/04 adminstration on postoperative complications: A prospective randomized trial in patients undergoing colorectal surgery. not-yet-due
Ongoing 2008-001669-27 A phase-III study on the value of allogeneic stem cell transplantation in poor-risk chronic lymphocytic leukemia by the German CLL Study Group (GCLLSG) and the German Cooperative Transplant Study Grou... not-yet-due
Not reported 2008-001787-36 Verbessert die perioperative Applikation von Esketamin in subanästhetischer Dosierung die postoperative Analgesie? 2011-02-28 due-trials
Not reported 2008-002269-29 A prospective, randomized, double-blind, multicenter, Phase III clinical study on transarterial chemoembolisation (TACE) combined with Sorafenib vs. TACE plus placebo in patients with hepatocellular c... 2013-02-18 due-trials
Not reported 2008-002667-13 A single-center controlled pilot study to investigate pre- and perioperative therapy with Sorafenib (Nexavar®) in patients who are candidates for a curative surgery of renal cell cancer (PREST = preop... 2013-09-10 due-trials
Ongoing 2008-003174-18 Open-labeled, randomized multi-center phase II study evaluating the efficacy and safety of Paclitaxel/ Carboplatin with and without Cetuximab as first-line treatment of adeno- and undifferentiated car... not-yet-due
Not reported 2008-004696-22 An Open Label Randomized Multicentre Phase IIIb Trial Comparing Parenteral Substitution versus Best Supportive Nutritional Care in Subjects with Pancreatic Adenocarcinoma Receiving 5-FU plus Oxaliplat... 2014-08-21 due-trials
Listed as ongoing, but also has a completion date 2008-005653-37 Multicenter, prospective randomized trial on the use of prothrombin complex and fresh frozen plasma in patients with intracerebral hemorrhage related to vitamin K antagonists (VKA) 2015-02-06 bad-data
Not reported 2008-006871-60 Dose-intensified Rechallenge with Temozolomide, One Week on One Week Off versus Three Weeks on One Week Off in Patients with Progressive or Recurrent Glioblastoma 2013-06-30 due-trials
Not reported 2008-008513-19 Phase II Studie zur Wirksamkeit und Verträglichkeit von Vorinostat bei Patienten mit fortgeschrittenen, metastasierten Weichteilsarkomen. English title: A Phase II Study to Investigate the Efficacy an... 2013-09-13 due-trials
Completed, but no date 2009-009277-10 Neoadjuvant Radiochemotherapy Combined with Panitumumab in Locally Advanced KRAS wild-type Rectal Cancer bad-data
Ongoing 2009-009426-81 Contrast-enhanced Imaging of the Abdomen: Gadovist® vs. Dotarem® – Intraindividual comparison of 0.1mmol/kg bw gadoterate meglumine with 0.1mmol/kg bw gadobutrol for dynamic abdominal imaging in patie... not-yet-due
Other 2009-009894-88 Lapatinib versus Lapatinib with Capecitabine as Second-line Treatment in Her2-Overexpressing Metastatic Gastro-Esophageal Cancer: A randomized phase II trial not-yet-due
Not reported 2009-011095-30 Intra-individual comparison of Gd-EOB-DTPA disodium (Primovist) and Gadobutrol (Gadovist) in patients with suspicion of hepatocellular carcinoma 2013-08-08 due-trials
Not reported 2009-013279-23 In vivo response monitoring of treatment with the EGFR-monoclonal-antibody Cetuximab in metastatic colorectal cancer – a single center phase II study 2016-12-21 due-trials
Not reported 2009-013856-61 A phase III national, multicentre, randomized open-label study with Lenalidomide/Dexamethasone versus Lenalidomide/Dexamethasone and autologous stem cell transplantation followed by Lenalidomide 2017-06-30 due-trials
Completed, but no date 2009-016489-10 Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced ... bad-data
Completed, but no date 2009-016631-35 Phase II Trial of Ipilimumab in Patients with advanced melanoma and spontaneous preexisting immune response to NY-ESO-1 bad-data
Completed, report not yet due 2009-017328-25 A phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer 2015-10-15 not-yet-due
Completed, but no date 2010-019173-16 Randomised phase III trial for previously untreated multiple myeloma to evaluate two regimens of bortezomib based induction therapy and lenalidomide consolidation followed by lenalidomide maintenance ... bad-data
Not reported 2010-019748-38 Hautveränderungen bei Patienten mit Kopf- und Halstumor unter kombinierter RadioImmuno-(chemo)-therapie mit Erbitux® 2015-11-04 due-trials
Ongoing 2010-022425-15 ACCEPT - (ACC, Erbitux® and particle therapy) - Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost (Phase I/II feasibility study) not-yet-due
Listed as ongoing, but also has a completion date 2011-000440-22 Multicenter prospective trial estimating the persistence of molecular remission in chronic myeloid leukemia after stopping TKI 2017-11-20 bad-data
Completed, report not yet due 2011-000921-61 A phase I/II, randomized, open-label, multi-centre study of BIBF1120 + reirradiation (R-RT) versus reirradiation in the treatment of patients with first or second progression of glioblastoma 2017-09-30 not-yet-due
Ongoing 2011-001491-20 A phase II trial to evaluate the safety, feasibility and efficacy of a salvage therapy consisting of the mTOR inhibitor Temsirolimus (Torisel™) added to the standard therapy of Rituximab and DHAP for ... not-yet-due
Not reported 2011-003273-28 Treatment of patients with metastatic melanoma (AJCC stage IV or III unresectable) with the PDE-inhibitor Tadalafil: A Pilot Trial for “Proof of Principle” 2015-03-25 due-trials
Not reported 2011-003745-18 A PHASE II WINDOW-OF-OPPORTUNITY STUDY OF 2016-12-31 due-trials
Not reported 2012-001650-26 A randomised, placebo-controlled, double-blind, monocentre study on the application of physostigminsalicylate (Anticholium®) as adjunctive measure in perioperative sepsis/septic shock 2017-02-18 due-trials
Completed, but no date 2012-003528-19 STEM CELL TRANSPLANTATION FOR ERADICATION OF MINIMAL bad-data
Listed as ongoing, but also has a completion date 2012-003609-80 European Cooperative Acute Stroke Study-4: Extending the time for thrombolysis in emergency neurological deficits. 2017-12-18 bad-data
Ongoing 2012-005846-39 Phase II, multicenter, open-label, single-arm trial in advanced and relapsed Angiosarcomas, to evaluate the efficacy of pazopanib (Votrient) in combination with standard of care treatment paclitaxel (... not-yet-due
Completed, but no date 2013-000211-24 A multicenter, randomized, placebo-controlled, double-blind proof of concept study to evaluate the efficacy and safety of the human normal immunoglobulin Intratect® 5% for intravenous use as adjuvant ... bad-data
Not reported 2013-001613-33 Iloprost for Bridging to Heart Transplantation in Patients with Pulmonary Hypertension and Left Heart Failure 2015-03-17 due-trials
Ongoing 2013-005485-19 Bendamustine, Prednisone and Velcade® for first-line treatment of patients with symptomatic multiple myeloma not eligible for high-dose chemotherapy followed by autologous stem cell transplantation (B... not-yet-due
Ongoing 2014-000924-11 Phase IIA Study on therapy with the NF-kB inhibiting and apoptosis inducing drug dimethylfumarate (DMF) in Patients with Cutaneous T cell lymphoma. not-yet-due
Completed, report not yet due 2014-001882-28 Early Treatment of Borderline Pulmonary Arterial Hypertension Associated with Systemic Sclerosis (SSc-APAH) 2017-11-27 not-yet-due
Ongoing 2014-001991-76 Initial treatment of idiopathic nephrotic syndrome in children with mycophenolate mofetil vs. prednisone: A randomized, controlled, multicenter study not-yet-due
Ongoing 2014-003079-40 A randomized phase III trial on the effect of elotuzumab in VRD induction /consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma not-yet-due
Ongoing 2015-001309-14 Comparison of the efficacy of using a human acellular dermis (Epiflex®) against the surgical standard procedure for closing an open abdomen with respect to avoiding ventral hernia. not-yet-due
Ongoing 2015-002752-27 Umbrella protocol for phase I/IIa trials of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed glioblastoma without MGMT promoter methylation: NCT Neuro Master M... not-yet-due
Ongoing 2015-003920-30 Phase-II study on the value of post-transplant Cyclophosphamide after Thiotepa-based haplo-identical stem-cell transplantation for relapsed-refractory lymphoma not-yet-due
Ongoing 2015-004998-33 Multicenter prospective trial after first unsuccesful treatment discontinuation in chronic myeloid leukemia estimating the efficacy of nilotinib in inducing the persistance of molecular remission afte... not-yet-due
Ongoing 2016-002059-89 Therapy of Nodal Follicular Non-Hodgkin Lymphoma (WHO grade 1/2) in Clinical Stage I/II using Response Adapted Involved Site Radiotherapy in Combination with Gazyvaro not-yet-due
Ongoing 2016-004660-19 CDK4/6 inhibition in locally advanced/metastatic chordoma not-yet-due
Ongoing 2016-004808-60 Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector - A unicenter Phase I /II clinical trial not-yet-due
Ongoing 2017-000514-35 Prospective Randomised Open-label Trial to Evaluate risk faCTor management in patients with Unruptured intracranial aneurysms (PROTECT-U) not-yet-due
Ongoing 2017-004768-37 A randomized phase III trial assessing the benefit of the addition of isatuximab to lenalidomide / bortezomib / dexamethasone (RVd) induction and lenalidomide maintenance in patients with newly diagno... not-yet-due